Table 1.
Scenario | Protection period | Efficacy against cases | Efficacy against hospitalization | COVID-19 case incidence | COVID-19 hospitalization incidence |
Vaccine attributable myocarditis/pericarditis death rate |
---|---|---|---|---|---|---|
Scenario 1 | 6 months | 90% | 90% | July 10, 2021 rate | July 10, 2021 rate | 0% |
Scenario 2 (Most Likely) | 6 months | 70% | 80% | 10× July 10, 2021 rate | 4× July 10,2021 rate | 0% |
Scenario 3 (Worst-Case) | 6 months | 70% | 80% | July 10, 2021 rate | July 10, 2021 rate | 0.002% |